Biogenity was founded in the summer of 2018 and is a biotechnology company focusing on expression data analysis for the preclinical-phases.
The omics technologies are advancing vastly and dominating discovery-based studies for biomarkers. These methods can deliver above 10.000 readings per sample, thus generating a large amount of data, which can be overwhelming for the researcher if not a data-specialist.
Biogenity's vision is to make data easy to manage and interpret. Thus a deeper and more precise understanding of the data is provided. We will achieve this by making advanced data analyzes accessible for all sizes of enterprises and researchers with one mission: To fuel and focus the search of new biomarkers for disease and better treatments hereof.
Ph.D. in Biomedical Science and Engineering
Phone: (+45) 71110509
MSc in Information Technology
Phone: (+45) 71116050
We base large parts of our product development on our unique pipeline. It can automate much of the process during data analysis by using the right tests for decision making. The programming behind the technology has been developed in-house, still based on the state of the art biostatistical methods and machine learning.
At Biogenity, we have developed our expression engine, which we in daily terms call NGEN. This powerful engine uses machine learning to sort and analyze your data; making all the right analytical decisions when processing.
The Next-Generation Engine allows automating otherwise monotonous and time-consuming tasks when processing expression data. The result hereof is a premium analysis at a low cost.
We keep optimizing our products to include more types of expression analyzes and make sure the methods used are up-to-date. We strive to ensure our customers to have the best possible understanding of their data to generate their hypotheses and conclusions.
We are also developing pipelines to utilize artificial intelligence-based methods to bring big data into personalized medicine. It is our goal to make big data a usable tool for biomarker-validation and discovery accessible for all sizes of Enterprises and researchers.